Where do Royalty Pharma's ratios come from?

Every ratio is computed from Royalty Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Royalty Pharma RPRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	275.7%+23.6pp	294.6%+84.5pp	286.1%+69.7pp	289%—	252.1%—
Net margin	143.3%-23.6pp	157.7%+3.4pp	163.2%-1.3pp	181.1%—	166.9%—
Returns
Return on equity	34.4%-3.6pp	37.2%+2.2pp	37.9%-0.2pp	41.7%—	38%—
Return on assets	18.3%-3.8pp	20.3%-0.1pp	21.2%-1.1pp	23.9%—	22.1%—
Return on invested capital	38.3%+2.2pp	41.2%+11.0pp	40.2%+8.1pp	41%—	36%—
Efficiency
Asset turnover	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Liquidity
Current ratio	9.8×-4.1×	8.7×-16.1×	7.7×-23.6×	5.8×-37.5×	13.9×-22.6×
Quick ratio	9.8×-4.1×	8.7×-16.1×	7.7×-23.6×	5.8×-37.5×	13.9×-22.6×
Cash ratio	4.4×-4.5×	4.2×-10.5×	4×-13.0×	3×-20.4×	8.9×-10.0×
Leverage
Debt-to-equity	3.6×+0.6×	3.5×+0.6×	3.3×+0.5×	3.1×+0.5×	3×+0.4×
Debt-to-assets	1.8×+0.1×	1.8×+0.1×	1.8×+0.1×	1.7×+0.1×	1.7×+0.1×
Interest coverage	22.2×-3.8×	25.2×+1.8×	25.8×+0.2×	27.8×—	26×—
Per Share
Book value per share	$69.15+1.7%	$68.22+1.0%	$68.41+2.3%	$68.53+4.6%	$67.97+4.0%
Valuation
Market capitalization	$67.54B+36.7%	$60.48B+22.2%	$55.3B+9.1%	$52.73B+5.0%	$49.42B-5.1%
Enterprise value	$99.7B+32.7%	$90.78B+22.7%	$83.93B+13.2%	$79.99B+10.8%	$75.13B+2.7%
Price / earnings	81×+26.7×	68.5×+9.6×	60.3×+3.5×	51.5×—	54.3×—
Price / sales	28.5×+6.6×	26×+4.0×	24.1×+1.8×	23.2×+1.2×	21.9×-0.6×
Price / book	7×+2.0×	6.3×+1.3×	5.7×+0.6×	5.3×+0.2×	4.9×-0.4×
EV / sales	42×+8.8×	39×+6.2×	36.5×+3.9×	35.1×+3.6×	33.3×+1.7×
Earnings yield	20.4%-9.9pp	24.5%-3.6pp	27.4%-2.2pp	31.4%—	30.4%—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Royalty Pharma.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Royalty Pharma's ratios come from?: Every ratio is computed from Royalty Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.